Volumetric staging in oropharyngeal cancer patients treated with definitive IMRTSTUDER, Gabriela; GLANZMANN, Christoph.Oral oncology (1997). 2013, Vol 49, Num 3, pp 269-276, issn 1368-8375, 8 p.Article

SURVIVING HYPOPHARYNX-LARYNX CARCINOMA IN THE ERA OF IMRTSTUDER, Gabriela; PEPONI, Evangelia; KLOECK, Stephan et al.International journal of radiation oncology, biology, physics. 2010, Vol 77, Num 5, pp 1391-1396, issn 0360-3016, 6 p.Article

GRADE 3/4 DERMATITIS IN HEAD AND NECK CANCER PATIENTS TREATED WITH CONCURRENT CETUXIMAB AND IMRTSTUDER, Gabriela; BROWN, Michelle; GLANZMANN, Christoph et al.International journal of radiation oncology, biology, physics. 2011, Vol 81, Num 1, pp 110-117, issn 0360-3016, 8 p.Article

Protein kinase C inhibitor and irradiation-induced apoptosis: Relevance of the cytochrome c-mediated caspase-9 death pathwayROCHA, Sonia; SOENGAS, Maria S; LOWE, Scott W et al.Cell growth and differentiation. 2000, Vol 11, Num 9, pp 491-499, issn 1044-9523Article

Concomitant cisplatin significantly improves locoregional control in advanced head and neck cancers treated with hyperfractionated radiotherapyHUGUENIN, Pia; BEER, Karl T; BERNIER, Jacques et al.Journal of clinical oncology. 2004, Vol 22, Num 23, pp 4613-4621, issn 0732-183X, 9 p.Article

Key targets for the execution of radiation-induced tumor cell apoptosis : The role of p53 and caspasesPRUSCHY, Martin; ROCHA, Sonia; ZAUGG, Kathrin et al.International journal of radiation oncology, biology, physics. 2001, Vol 49, Num 2, pp 561-567, issn 0360-3016Conference Paper

Differential activation of the phosphatidylinositol 3'-kinase/Akt survival pathway by ionizing radiation in tumor and primary endothelial cellsZINGG, Daniel; RIESTERER, Oliver; FABBRO, Doriano et al.Cancer research (Baltimore). 2004, Vol 64, Num 15, pp 5398-5406, issn 0008-5472, 9 p.Article

CONCOMITANT CISPLATIN AND HYPERFRACTIONATED RADIOTHERAPY IN LOCALLY ADVANCED HEAD-AND-NECK CANCER: 10-YEAR FOLLOW-UP OF A RANDOMIZED PHASE III TRIAL (SAKK 10/94)GHADJAR, Pirus; SIMCOCK, Mathew; AEBERSOLD, Daniel M et al.International journal of radiation oncology, biology, physics. 2012, Vol 82, Num 2, pp 524-531, issn 0360-3016, 8 p.Article

GEFITINIB IN COMBINATION WITH IRRADIATION WITH OR WITHOUT CISPLATIN IN PATIENTS WITH INOPERABLE STAGE III NON-SMALL CELL LUNG CANCER: A PHASE I TRIALROTHSCHILD, Sacha; BUCHER, Stephan E; CIERNIK, I. Frank et al.International journal of radiation oncology, biology, physics. 2011, Vol 80, Num 1, pp 126-132, issn 0360-3016, 7 p.Article

The Use of Photon Beams of a Flattening Filter-free Linear Accelerator for Hypofractionated Volumetric Modulated Arc Therapy in Localized Prostate CancerZWAHLEN, Daniel R; LANG, Stephanie; HRBACEK, Jan et al.International journal of radiation oncology, biology, physics. 2012, Vol 83, Num 5, pp 1655-1660, issn 0360-3016, 6 p.Article

Differential p53-dependent mechanism of radiosensitization in vitro and in vivo by the protein kinase C-specific inhibitor PKC412ZAUGG, Kathrin; ROCHA, Sonia; RESCH, Hildegard et al.Cancer research (Baltimore). 2001, Vol 61, Num 2, pp 732-738, issn 0008-5472Article

The phosphatidylinositide 3'-kinase/akt survival pathway is a target for the anticancer and radiosensitizing agent PKC412, an inhibitor of protein kinase CTENZER, Angela; ZINGG, Daniel; ROCHA, Sonia et al.Cancer research (Baltimore). 2001, Vol 61, Num 22, pp 8203-8210, issn 0008-5472Article